EWA
GILD icon

Evolution Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Evolution Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-184
Closed -$13K – 346
2021
Q3 		$13K Sell
184
-212
-54% -$14.9K ﹤0.01% 367
2021
Q2 		$27K Hold
396
– – 0.01% 269
2021
Q1 		$26K Buy
396
+10
+3% +$645 0.01% 263
2020
Q4 		$22K Sell
386
-300
-44% -$18.1K 0.01% 252
2020
Q3 		$43K Sell
686
-12
-2% -$832 0.01% 195
2020
Q2 		$54K Buy
698
+220
+46% +$16.9K 0.02% 138
2020
Q1 		$36K Sell
478
-9,296
-95% -$642K 0.01% 128
2019
Q4 		$52K Buy
9,774
+9,519
+3,733% +$620K 0.01% 146
2019
Q3 		$16K Sell
255
-421
-62% -$27.5K 0.01% 121
2019
Q2 		$46K Buy
+676
New +$44.5K 0.02% 87

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Evolution Wealth Advisors's GILD Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 184 shares — an estimated $13K sold.

Evolution Wealth Advisors first reported a position in GILD in Q2 2019 and held it in 10 quarters. The position peaked at $54K in Q2 2020. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Evolution Wealth Advisors reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 184 Gilead Sciences shares in Q4 2021, an estimated $13K.
  • Evolution Wealth Advisors first reported a position in Gilead Sciences in Q2 2019 and held it in 10 quarters.
  • Evolution Wealth Advisors's Gilead Sciences position peaked at $54K in Q2 2020.
  • 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.